DOCSLIB.ORG

Frog Antibodies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Frog Antibodies Frog Antibodies gene_name sku Entry_Name Protein_Names Organism Length Identity e2f4 ARP31175_P050 Q6DE14_XENLA E2f4‐prov protein Xenopus laevis (African clawed frog) 375 92.00% Xenopus tropicalis (Western clawed frog) e2f4 ARP31175_P050 B0JZ97_XENTR E2f4 protein (Silurana tropicalis) 374 92.00% General transcription factor 2F, polypeptide 2, Xenopus tropicalis (Western clawed frog) LOC511494 ARP31437_P050 Q6P8B7_XENTR 30kDa (Silurana tropicalis) 264 85.00% General transcription factor IIF subunit 2 (EC 3.6.4.12) (ATP‐dependent helicase gtf2f2) (Transcription initiation factor IIF subunit beta) (TFIIF‐beta) (Transcription initiation LOC511494 ARP31437_P050 T2FB_XENLA factor RAP30) Xenopus laevis (African clawed frog) 264 85.00% ORF Names:PANDA_000462 EMBL EFB13877.1OrganismAiluropoda melanoleuca (Giant panda) ARP31939_P050 Q8AVU3_XENLA MGC52825 protein Xenopus laevis (African clawed frog) 212 92.00% ORF Names:PANDA_000462 EMBL EFB13877.1OrganismAiluropoda Xenopus tropicalis (Western clawed frog) melanoleuca (Giant panda) ARP31939_P050 Q6P7M9_XENTR High‐mobility group box 2 (Silurana tropicalis) 212 92.00% ORF Names:PANDA_000462 EMBL EFB13877.1OrganismAiluropoda melanoleuca (Giant panda) ARP31939_P050 Q32NS7_XENLA MGC52825 protein Xenopus laevis (African clawed frog) 211 92.00% ORF Names:PANDA_000462 EMBL EFB13877.1OrganismAiluropoda melanoleuca (Giant panda) ARP31939_P050 Q91764_XENLA HMG‐X protein Xenopus laevis (African clawed frog) 212 84.00% ORF Names:PANDA_000462 EMBL EFB13877.1OrganismAiluropoda melanoleuca (Giant panda) ARP31939_P050 Q7ZXK5_XENLA MGC52578 protein Xenopus laevis (African clawed frog) 212 84.00% Agpat5 ARP47429_P050 Q6NS16_XENLA MGC78843 protein Xenopus laevis (African clawed frog) 397 85.00% irf9 ARP31200_P050 Q6NS16_XENLA MGC78843 protein Xenopus laevis (African clawed frog) 397 85.00% ARP47492_P050 Q98SF3_XENLA Lhx7 protein (Fragment) Xenopus laevis (African clawed frog) 74 85.00% ARP47492_P050 Q6PF48_XENLA MGC68912 protein Xenopus laevis (African clawed frog) 282 85.00% Xenopus tropicalis (Western clawed frog) ARP47492_P050 Q28CD2_XENTR LIM homeobox 7/8 (LIM homeobox 8) (Silurana tropicalis) 374 85.00% Lhx6 ARP31999_P050 Q98SF3_XENLA Lhx7 protein (Fragment) Xenopus laevis (African clawed frog) 74 85.00% Lhx6 ARP31999_P050 Q6PF48_XENLA MGC68912 protein Xenopus laevis (African clawed frog) 282 85.00% Xenopus tropicalis (Western clawed frog) Lhx6 ARP31999_P050 Q28CD2_XENTR LIM homeobox 7/8 (LIM homeobox 8) (Silurana tropicalis) 374 85.00% XSu(H)1 ARP31121_P050 A3KMT5_XENLA XSu(H)1 protein Xenopus laevis (African clawed frog) 487 92.00% XSu(H)1 ARP31121_P050 SUH_XENLA Isoform 2 (Isoform X‐Su(H)2) Xenopus laevis (African clawed frog) 481 92.00% Suppressor of hairless protein homolog (X‐ XSu(H)1 ARP31121_P050 SUH_XENLA Su(H)) Xenopus laevis (African clawed frog) 501 92.00% Xenopus tropicalis (Western clawed frog) ARP47372_P050 B1H0Z0_XENTR LOC100145280 protein (Silurana tropicalis) 301 78.00% ARP47372_P050 A9JS93_XENLA LOC100127342 protein (Fragment) Xenopus laevis (African clawed frog) 298 78.00% RNF6 ARP32151_P050 Q7T036_XENLA XRnf12C Xenopus laevis (African clawed frog) 825 100.00% Xenopus tropicalis (Western clawed frog) RNF6 ARP32151_P050 B7ZUL1_XENTR Ring finger protein, LIM domain interacting (Silurana tropicalis) 639 100.00% RNF6 ARP32151_P050 B7ZR09_XENLA XRnf12C protein Xenopus laevis (African clawed frog) 751 100.00% RNF6 ARP32151_P050 RF12A_XENLA Isoform 2 Xenopus laevis (African clawed frog) 616 100.00% E3 ubiquitin‐protein ligase RNF12 (EC 6.3.2.‐) Xenopus tropicalis (Western clawed frog) RNF6 ARP32151_P050 RNF12_XENTR (RING finger protein 12) (Silurana tropicalis) 639 100.00% E3 ubiquitin‐protein ligase RNF12‐B (EC 6.3.2.‐ RNF6 ARP32151_P050 RF12B_XENLA ) (RING finger protein 12‐B) (XRnf12B) Xenopus laevis (African clawed frog) 757 100.00% E3 ubiquitin‐protein ligase RNF12‐A (EC 6.3.2.‐ RNF6 ARP32151_P050 RF12A_XENLA ) (RING finger protein 12‐A) (XRnf12) Xenopus laevis (African clawed frog) 622 100.00% ORF Names:v1g86891OrganismNematostell a vectensis (Starlet sea anemone) ARP32390_P050 Q68F47_XENLA MGC81733 protein Xenopus laevis (African clawed frog) 309 85.00% ORF Names:v1g86891OrganismNematostell a vectensis (Starlet sea anemone) ARP32390_P050 Q5HZN8_XENLA LOC496346 protein Xenopus laevis (African clawed frog) 309 85.00% LOC100037026 ARP31531_P050 A9JS29_XENLA Putative uncharacterized protein Xenopus laevis (African clawed frog) 257 100.00% LOC100037026 ARP31531_P050 A2VDE3_XENLA LOC100037233 protein (Fragment) Xenopus laevis (African clawed frog) 255 100.00% LOC100037026 ARP31531_P050 A1L3J8_XENLA LOC100037026 protein Xenopus laevis (African clawed frog) 258 100.00% Vacuolar‐sorting protein SNF8 (ESCRT‐II Xenopus tropicalis (Western clawed frog) LOC100037026 ARP31531_P050 SNF8_XENTR complex subunit VPS22) (Silurana tropicalis) 257 100.00% Xenopus tropicalis (Western clawed frog) tcf4 ARP33413_P050 A4IIL9_XENTR Tcf4 protein (Fragment) (Silurana tropicalis) 345 85.00% laptm4b ARP47442_P050 B1H1Y1_XENLA LOC100158325 protein Xenopus laevis (African clawed frog) 225 78.00% Xenopus tropicalis (Western clawed frog) ARP47666_P050 B6ICZ8_XENTR Putative uncharacterized protein (Silurana tropicalis) 528 78.00% ARP47666_P050 Q6IR95_XENLA MGC80043 protein Xenopus laevis (African clawed frog) 513 78.00% Xenopus tropicalis (Western clawed frog) Fam70a ARP47380_P050 Q5HZT3_XENTR Hypothetical LOC497005 (Silurana tropicalis) 235 83.00% Fam70a ARP47380_P050 FA70A_XENLA Protein FAM70A Xenopus laevis (African clawed frog) 321 83.00% Xenopus tropicalis (Western clawed frog) etv7 P100807_P050 Q28DU7_XENTR Ets variant gene 6 (TEL oncogene) (Silurana tropicalis) 450 100.00% Xenopus tropicalis (Western clawed frog) etv7 P100807_P050 Q0IHQ4_XENTR Ets variant 6 (Silurana tropicalis) 450 100.00% etv7 P100807_P050 B3VKU4_XENLA Ets variant 6 Xenopus laevis (African clawed frog) 448 100.00% Activity‐dependent neuroprotector Xenopus tropicalis (Western clawed frog) Adnp ARP39186_P050 Q28CN1_XENTR (Fragment) (Silurana tropicalis) 864 92.00% ORF Names:CH211‐145O7.4‐001 EMBL CAM12896.1OrganismDanio rerio Xenopus tropicalis (Western clawed frog) (Zebrafish) (Brachydanio rerio) ARP31377_P050 A4IGZ5_XENTR LOC100038288 protein (Fragment) (Silurana tropicalis) 306 84.00% ORF Names:CH211‐145O7.4‐001 EMBL CAM12896.1OrganismDanio rerio (Zebrafish) (Brachydanio rerio) ARP31377_P050 Q91639_XENLA Fos‐related antigen‐2 Xenopus laevis (African clawed frog) 319 84.00% ORF Names:CH211‐145O7.4‐001 EMBL CAM12896.1OrganismDanio rerio (Zebrafish) (Brachydanio rerio) ARP31377_P050 B7ZR03_XENLA Fos‐related antigen‐2 Xenopus laevis (African clawed frog) 319 84.00% ORF Names:CH211‐145O7.4‐001 EMBL CAM12896.1OrganismDanio rerio V‐fos FBJ murine osteosarcoma viral Xenopus tropicalis (Western clawed frog) (Zebrafish) (Brachydanio rerio) ARP31377_P050 Q28CJ5_XENTR oncogene homolog (Silurana tropicalis) 368 76.00% fosl2 ARP31277_P050 Q91639_XENLA Fos‐related antigen‐2 Xenopus laevis (African clawed frog) 319 81.00% fosl2 ARP31277_P050 B7ZR03_XENLA Fos‐related antigen‐2 Xenopus laevis (African clawed frog) 319 81.00% Heat shock cognate 70.II (Heat shock cognate Hspa1l ARP48445_P050 Q91993_XENLA 70.II protein) Xenopus laevis (African clawed frog) 647 100.00% Hspa1l ARP48445_P050 Q8AVE2_XENLA Hsc70 protein Xenopus laevis (African clawed frog) 650 100.00% Hspa1l ARP48445_P050 Q7ZTK6_XENLA MGC53952 protein Xenopus laevis (African clawed frog) 646 100.00% Hspa1l ARP48445_P050 Q6DCD3_XENLA Hsp70 protein Xenopus laevis (African clawed frog) 647 100.00% Hspa1l ARP48445_P050 Q6AZH8_XENLA Putative uncharacterized protein Xenopus laevis (African clawed frog) 652 100.00% Xenopus tropicalis (Western clawed frog) Hspa1l ARP48445_P050 Q0V9A5_XENTR Heat shock 70kDa protein 1‐like (Silurana tropicalis) 639 100.00% Xenopus tropicalis (Western clawed frog) Hspa1l ARP48445_P050 A9JTJ5_XENTR Hsp70 protein (Silurana tropicalis) 643 100.00% Xenopus tropicalis (Western clawed frog) Hspa1l ARP48445_P050 A4IGS8_XENTR Hsp70 protein (Fragment) (Silurana tropicalis) 507 100.00% Hspa1l ARP48445_P050 A1L3K5_XENLA LOC100037033 protein Xenopus laevis (African clawed frog) 646 100.00% Xenopus tropicalis (Western clawed frog) GATA3 ARP32548_P050 Q6DIQ6_XENTR GATA binding protein 3 (Silurana tropicalis) 437 78.00% GATA3 ARP32548_P050 Q2TAR8_XENLA XGATA‐3 protein Xenopus laevis (African clawed frog) 435 78.00% GATA‐binding factor 3 (Transcription factor GATA3 ARP32548_P050 GATA3_XENLA xGATA‐3) Xenopus laevis (African clawed frog) 435 78.00% Xenopus tropicalis (Western clawed frog) GSM1 ARP47383_P050 SOX9_XENTR Transcription factor Sox‐9 (Xt‐sox9) (Silurana tropicalis) 482 84.00% ORF Names:GSPATT00007737001 EMBL CAK70602.1OrganismParamecium tetraurelia P100987_P050 Q71N44_XENLA Transcription factor IIA large subunit Xenopus laevis (African clawed frog) 370 85.00% ORF Names:GSPATT00007737001 EMBL CAK70602.1OrganismParamecium TFIIAa/b‐2 protein (Transcription factor IIA tetraurelia P100987_P050 Q6XPY4_XENLA large subunit‐2) Xenopus laevis (African clawed frog) 367 85.00% ORF Names:GSPATT00007737001 EMBL CAK70602.1OrganismParamecium tetraurelia P100987_P050 Q6XPY2_XENLA Transcription factor IIA large subunit‐1 Xenopus laevis (African clawed frog) 370 85.00% ORF Names:GSPATT00007737001 EMBL CAK70602.1OrganismParamecium tetraurelia P100987_P050 Q6ING6_XENLA TFIIAa/b‐2 protein (Fragment) Xenopus laevis (African clawed frog) 366 85.00% ORF Names:GSPATT00007737001 EMBL CAK70602.1OrganismParamecium tetraurelia P100987_P050 Q5HZB8_XENLA Putative uncharacterized protein Xenopus laevis (African
Load more

Recommended publications
  • Analysis of Trans Esnps Infers Regulatory Network Architecture
    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
    [Show full text]
  • A Germline-Specific Isoform of Eif4e (IFE-1) Is Required for Efficient Translation of Stored Mrnas and Maturation of Both Oocytes and Sperm
    Research Article 1529 A germline-specific isoform of eIF4E (IFE-1) is required for efficient translation of stored mRNAs and maturation of both oocytes and sperm Melissa A. Henderson1, Elizabeth Cronland1, Steve Dunkelbarger2, Vince Contreras1, Susan Strome2 and Brett D. Keiper1,* 1Department of Biochemistry and Molecular Biology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA 2Department of Molecular Cell and Developmental Biology, University of California, Santa Cruz, CA 95064, USA *Author for correspondence (e-mail: [email protected]) Accepted 26 January 2009 Journal of Cell Science 122, 1529-1539 Published by The Company of Biologists 2009 doi:10.1242/jcs.046771 Summary Fertility and embryonic viability are measures of efficient germ CED-4/Apaf-1, and accumulated as multinucleate cells unable cell growth and development. During oogenesis and to mature to spermatids. A modest defect in oocyte development spermatogenesis, new proteins are required for both mitotic was also observed. Oocytes progressed normally through mitosis expansion and differentiation. Qualitative and quantitative and meiosis, but subsequent production of competent oocytes changes in protein synthesis occur by translational control of became limiting, even in the presence of wild-type sperm. mRNAs, mediated in part by eIF4E, which binds the mRNAs Combined gametogenesis defects decreased worm fertility by 5Ј cap. IFE-1 is one of five eIF4E isoforms identified in 80% at 20°C; ife-1 worms were completely sterile at 25°C. C. elegans. IFE-1 is expressed primarily in the germ line and Thus, IFE-1 plays independent roles in late oogenesis and associates with P granules, large mRNPs that store mRNAs.
    [Show full text]
  • Sanjay Kumar Gupta
    The human CCHC-type Zinc Finger Nucleic Acid Binding Protein (CNBP) binds to the G-rich elements in target mRNA coding sequences and promotes translation Das humane CCHC-Typ-Zinkfinger-Nukleinsäure-Binde-Protein (CNBP) bindet an G-reiche Elemente in der kodierenden Sequenz seiner Ziel-mRNAs und fördert deren Translation Doctoral thesis for a doctoral degree at the Graduate School of Life Sciences, Julius-Maximilians-Universität WürzBurg, Section: Biomedicine suBmitted By Sanjay Kumar Gupta from Varanasi, India WürzBurg, 2016 1 Submitted on: …………………………………………………………..…….. Office stamp Members of the Promotionskomitee: Chairperson: Prof. Dr. Alexander Buchberger Primary Supervisor: Dr. Stefan Juranek Supervisor (Second): Prof. Dr. Utz Fischer Supervisor (Third): Dr. Markus Landthaler Date of Public Defence: …………………………………………….………… Date of Receipt of Certificates: ………………………………………………. 2 Summary The genetic information encoded with in the genes are transcribed and translated to give rise to the functional proteins, which are building block of a cell. At first, it was thought that the regulation of gene expression particularly occurs at the level of transcription By various transcription factors. Recent discoveries have shown the vital role of gene regulation at the level of RNA also known as post-transcriptional gene regulation (PTGR). Apart from non-coding RNAs e.g. micro RNAs, various RNA Binding proteins (RBPs) play essential role in PTGR. RBPs have been implicated in different stages of mRNA life cycle ranging from splicing, processing, transport, localization and decay. In last 20 years studies have shown the presence of hundreds of RBPs across eukaryotic systems many of which are widely conserved. Given the rising numBer of RBPs and their link to human diseases it is quite evident that RBPs have major role in cellular processes and their regulation.
    [Show full text]
  • The Zinc-Finger Protein CNBP Is Required for Forebrain Formation In
    Development 130, 1367-1379 1367 © 2003 The Company of Biologists Ltd doi:10.1242/dev.00349 The zinc-finger protein CNBP is required for forebrain formation in the mouse Wei Chen1,2, Yuqiong Liang1, Wenjie Deng1, Ken Shimizu1, Amir M. Ashique1,2, En Li3 and Yi-Ping Li1,2,* 1Department of Cytokine Biology, The Forsyth Institute, Boston, MA 02115, USA 2Harvard-Forsyth Department of Oral Biology, Harvard School of Dental Medicine, Boston, MA 02115, USA 3Cardiovascular Research Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Charlestown, MA 02129, USA *Author for correspondence (e-mail: [email protected]) Accepted 19 December 2002 SUMMARY Mouse mutants have allowed us to gain significant insight (AME), headfolds and forebrain. In Cnbp–/– embryos, the into axis development. However, much remains to be visceral endoderm remains in the distal tip of the conceptus learned about the cellular and molecular basis of early and the ADE fails to form, whereas the node and notochord forebrain patterning. We describe a lethal mutation mouse form normally. A substantial reduction in cell proliferation strain generated using promoter-trap mutagenesis. The was observed in the anterior regions of Cnbp–/– embryos at mutants exhibit severe forebrain truncation in homozygous gastrulation and neural-fold stages. In these regions, Myc mouse embryos and various craniofacial defects in expression was absent, indicating CNBP targets Myc in heterozygotes. We show that the defects are caused by rostral head formation. Our findings demonstrate that disruption of the gene encoding cellular nucleic acid Cnbp is essential for the forebrain induction and binding protein (CNBP); Cnbp transgenic mice were able specification.
    [Show full text]
  • Tomo-Seq Identifies SOX9 As a Key Regulator of Cardiac Fibrosis During Ischemic Injury
    myocardial myocardial Eva van ◼ osis fibr SOX9 transcription ◼ PhD* PhD PhD PhD MSc, PhD naarden, MSc, PhD naarden, PhD* ventricular remodeling Correspondence to: Correspondence Rooij, MSc, PhD, Hubrecht Department of Institute, KNAW University Medical Cardiology, Uppsalalaan 8, Center Utrecht, The Netherlands. 3584CT Utrecht, E-mail [email protected] of Funding, see page 1408 Sources Key Words: ischemia ◼ © 2017 American Heart Association, Inc. *Drs. Lacraz and Junker contributed equally. Grégory P.A. Lacraz, MSc, P.A. Grégory MSc, Jan Philipp Junker, Monika M. Gladka, MSc, MSc Bas Molenaar, Scholman, MSc Koen T. MSc Marta Vigil-Garcia, BS Danielle Versteeg, BS Hesther de Ruiter, MSc, Vermunt, Marit W. MSc, Creyghton, Menno P. Manon M.H. Huibers, Nicolaas de Jonge, MD Alexander van Oude- Eva van Rooij, MSc, PhD 2017;136:1396–1409. DOI: 10.1161/CIRCULATIONAHA.117.027832 DOI: 2017;136:1396–1409. Circulation. blunted the cardiac fibrotic fibrotic blunted the cardiac Sox9 ). Subsequent correlation analysis allowed). Subsequent correlation Serca2 Editorial, see p 1410 , and Nppa Based on the exact local expression cues, tomo-seq can Based on the exact local expression Cardiac ischemic injury induces a pathological remodeling ischemic injury induces a pathological remodeling Cardiac , Although genome-wide transcriptome analysis on diseased tissues Tracing transcriptional differences with a high spatial resolution with a high spatial resolution transcriptional differences Tracing Col1a2 October 10, 2017 October 10, 1396 CONCLUSIONS: novel genes and key transcription factors involved in specific serve to reveal able to unveil the Using tomo-seq, we were remodeling. aspects of cardiac pointing fibrosis, of cardiac of SOX9 as a key regulator unknown relevance fibrosis.
    [Show full text]
  • The Title of the Dissertation
    UNIVERSITY OF CALIFORNIA SAN DIEGO Novel network-based integrated analyses of multi-omics data reveal new insights into CD8+ T cell differentiation and mouse embryogenesis A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioinformatics and Systems Biology by Kai Zhang Committee in charge: Professor Wei Wang, Chair Professor Pavel Arkadjevich Pevzner, Co-Chair Professor Vineet Bafna Professor Cornelis Murre Professor Bing Ren 2018 Copyright Kai Zhang, 2018 All rights reserved. The dissertation of Kai Zhang is approved, and it is accept- able in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California San Diego 2018 iii EPIGRAPH The only true wisdom is in knowing you know nothing. —Socrates iv TABLE OF CONTENTS Signature Page ....................................... iii Epigraph ........................................... iv Table of Contents ...................................... v List of Figures ........................................ viii List of Tables ........................................ ix Acknowledgements ..................................... x Vita ............................................. xi Abstract of the Dissertation ................................. xii Chapter 1 General introduction ............................ 1 1.1 The applications of graph theory in bioinformatics ......... 1 1.2 Leveraging graphs to conduct integrated analyses .......... 4 1.3 References .............................. 6 Chapter 2 Systematic
    [Show full text]
  • Gentaur Products List
    Chapter 2 : Gentaur Products List • Rabbit Anti LAMR1 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Podoplanin gp36 Polyclonal Antibody Cy5 • Rabbit Anti LAMR1 CT Polyclonal Antibody Cy5 • Rabbit Anti phospho NFKB p65 Ser536 Polyclonal Conjugated Conjugated Antibody Cy5 Conjugated • Rabbit Anti CHRNA7 Polyclonal Antibody Cy5 Conjugated • Rat Anti IAA Monoclonal Antibody Cy5 Conjugated • Rabbit Anti EV71 VP1 CT Polyclonal Antibody Cy5 • Rabbit Anti Connexin 40 Polyclonal Antibody Cy5 • Rabbit Anti IAA Indole 3 Acetic Acid Polyclonal Antibody Conjugated Conjugated Cy5 Conjugated • Rabbit Anti LHR CGR Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Integrin beta 7 Polyclonal Antibody Cy5 • Rabbit Anti Natrexone Polyclonal Antibody Cy5 Conjugated • Rabbit Anti MMP 20 Polyclonal Antibody Cy5 Conjugated Conjugated • Rabbit Anti Melamine Polyclonal Antibody Cy5 Conjugated • Rabbit Anti BCHE NT Polyclonal Antibody Cy5 Conjugated • Rabbit Anti NAP1 NAP1L1 Polyclonal Antibody Cy5 • Rabbit Anti Acetyl p53 K382 Polyclonal Antibody Cy5 • Rabbit Anti BCHE CT Polyclonal Antibody Cy5 Conjugated Conjugated Conjugated • Rabbit Anti HPV16 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti CCP Polyclonal Antibody Cy5 Conjugated • Rabbit Anti JAK2 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HPV18 E6 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti HDC Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Microsporidia protien Polyclonal Antibody Cy5 • Rabbit Anti HPV16 E7 Polyclonal Antibody Cy5 Conjugated • Rabbit Anti Neurocan Polyclonal
    [Show full text]
  • Seq2pathway Vignette
    seq2pathway Vignette Bin Wang, Xinan Holly Yang, Arjun Kinstlick May 19, 2021 Contents 1 Abstract 1 2 Package Installation 2 3 runseq2pathway 2 4 Two main functions 3 4.1 seq2gene . .3 4.1.1 seq2gene flowchart . .3 4.1.2 runseq2gene inputs/parameters . .5 4.1.3 runseq2gene outputs . .8 4.2 gene2pathway . 10 4.2.1 gene2pathway flowchart . 11 4.2.2 gene2pathway test inputs/parameters . 11 4.2.3 gene2pathway test outputs . 12 5 Examples 13 5.1 ChIP-seq data analysis . 13 5.1.1 Map ChIP-seq enriched peaks to genes using runseq2gene .................... 13 5.1.2 Discover enriched GO terms using gene2pathway_test with gene scores . 15 5.1.3 Discover enriched GO terms using Fisher's Exact test without gene scores . 17 5.1.4 Add description for genes . 20 5.2 RNA-seq data analysis . 20 6 R environment session 23 1 Abstract Seq2pathway is a novel computational tool to analyze functional gene-sets (including signaling pathways) using variable next-generation sequencing data[1]. Integral to this tool are the \seq2gene" and \gene2pathway" components in series that infer a quantitative pathway-level profile for each sample. The seq2gene function assigns phenotype-associated significance of genomic regions to gene-level scores, where the significance could be p-values of SNPs or point mutations, protein-binding affinity, or transcriptional expression level. The seq2gene function has the feasibility to assign non-exon regions to a range of neighboring genes besides the nearest one, thus facilitating the study of functional non-coding elements[2]. Then the gene2pathway summarizes gene-level measurements to pathway-level scores, comparing the quantity of significance for gene members within a pathway with those outside a pathway.
    [Show full text]
  • Transcriptomic Analysis of the Aquaporin (AQP) Gene Family
    Pancreatology 19 (2019) 436e442 Contents lists available at ScienceDirect Pancreatology journal homepage: www.elsevier.com/locate/pan Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic markers in patients with pancreatic ductal adenocarcinoma Dimitrios E. Magouliotis a, b, Vasiliki S. Tasiopoulou c, Konstantinos Dimas d, * Nikos Sakellaridis d, Konstantina A. Svokos e, Alexis A. Svokos f, Dimitris Zacharoulis b, a Division of Surgery and Interventional Science, Faculty of Medical Sciences, UCL, London, UK b Department of Surgery, University of Thessaly, Biopolis, Larissa, Greece c Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece d Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece e The Warren Alpert Medical School of Brown University, Providence, RI, USA f Riverside Regional Medical Center, Newport News, VA, USA article info abstract Article history: Background: This study aimed to assess the differential gene expression of aquaporin (AQP) gene family Received 14 October 2018 interactome in pancreatic ductal adenocarcinoma (PDAC) using data mining techniques to identify novel Received in revised form candidate genes intervening in the pathogenicity of PDAC. 29 January 2019 Method: Transcriptome data mining techniques were used in order to construct the interactome of the Accepted 9 February 2019 AQP gene family and to determine which genes members are differentially expressed in PDAC as Available online 11 February 2019 compared to controls. The same techniques were used in order to evaluate the potential prognostic role of the differentially expressed genes. Keywords: PDAC Results: Transcriptome microarray data of four GEO datasets were incorporated, including 142 primary Aquaporin tumor samples and 104 normal pancreatic tissue samples.
    [Show full text]
  • Human Transcription Factor Protein-Protein Interactions in Health and Disease
    HELKA GÖÖS GÖÖS HELKA Recent Publications in this Series 45/2019 Mgbeahuruike Eunice Ego Evaluation of the Medicinal Uses and Antimicrobial Activity of Piper guineense (Schumach & Thonn) 46/2019 Suvi Koskinen AND DISEASE IN HEALTH INTERACTIONS PROTEIN-PROTEIN FACTOR HUMAN TRANSCRIPTION Near-Occlusive Atherosclerotic Carotid Artery Disease: Study with Computed Tomography Angiography 47/2019 Flavia Fontana DISSERTATIONES SCHOLAE DOCTORALIS AD SANITATEM INVESTIGANDAM Biohybrid Cloaked Nanovaccines for Cancer Immunotherapy UNIVERSITATIS HELSINKIENSIS 48/2019 Marie Mennesson Kainate Receptor Auxiliary Subunits Neto1 and Neto2 in Anxiety and Fear-Related Behaviors 49/2019 Zehua Liu Porous Silicon-Based On-Demand Nanohybrids for Biomedical Applications 50/2019 Veer Singh Marwah Strategies to Improve Standardization and Robustness of Toxicogenomics Data Analysis HELKA GÖÖS 51/2019 Iryna Hlushchenko Actin Regulation in Dendritic Spines: From Synaptic Plasticity to Animal Behavior and Human HUMAN TRANSCRIPTION FACTOR PROTEIN-PROTEIN Neurodevelopmental Disorders 52/2019 Heini Liimatta INTERACTIONS IN HEALTH AND DISEASE Efectiveness of Preventive Home Visits among Community-Dwelling Older People 53/2019 Helena Karppinen Older People´s Views Related to Their End of Life: Will-to-Live, Wellbeing and Functioning 54/2019 Jenni Laitila Elucidating Nebulin Expression and Function in Health and Disease 55/2019 Katarzyna Ciuba Regulation of Contractile Actin Structures in Non-Muscle Cells 56/2019 Sami Blom Spatial Characterisation of Prostate Cancer by Multiplex
    [Show full text]
  • Disease and Clinical Signs Poster
    African Clawed Frog Xenopus laevis Diseases and Clinical Signs in Photographs Therese Jones-Green University Biomedical Services Abstract Reported clinical signs associated with ill health and Clinical signs found between 2016 to 2018 Many diseases of Xenopus laevis frogs have been described in the • Opened in 2005, the biofacility can hold up to 900 female and 240 disease Clinical signs found between 2016 to 2018 male frogs in a Marine Biotech (now serviced by MBK Installations Ltd.) • 80 recirculating aquatic system. • Buoyancy problems 70 bridge this gap using photographs taken of frogs with clinical signs. The system monitors parameters such as: temperature, pH, • • Changes in activity e.g. lethargy or easily startled. My aims are: conductivity, and Total Gas Pressure. 60 • Unusual amount of skin shedding. 2018 • To share my experiences, via images, to help improve the welfare and • Frogs are maintained on mains fed water with a 20% water exchange. 50 ases • Weight loss, or failure to feed correctly. c husbandry of this species. • 2017 • Coelomic (body cavity) distention. 40 • To stimulate a dialogue which results in further sharing of ideas and 2016 Whole body bloat. 30 information. • Frogs are held under a 12 hour light/dark cycle. • Number of • Each tank has a PVC enrichment tube (30cm x 10cm), with smoothed • Fungal strands/tufts. 20 Introduction cut edges. • Sores or tremors at extremities (forearms and toes). 10 Between January 2016 and October 2018, cases of ill health and disease • Frogs are fed three times a week with a commercial trout pellet. • Redness or red spots. 0 Oedema Red leg Red leg (bad Red leg Gas bubble Sores on forearm Opaque cornea Skeletal Growth (cartilage Scar Cabletie Missing claws Eggbound in a colony of Xenopus laevis frogs housed by the University Biological hormone) (nematodes) disease deformity under skin) • The focus of the research undertaken in the biofacility is embryonic and • Excessive slime/mucous production or not enough (dry dull skin).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]